lifestyle.capitolhilltimes.com

Business

Latest Business News

THE SOVEREIGNTY DOCTRINE: 5 Assets Locking Down the 2026 Survival Cycle

USA News Group

February 11, 2026
Johnson Fistel, PLLP Begins Investigation on Behalf of Long-Term Shareholders of Hasbro, Inc. (HAS), Humana Inc. (HUM), Ibotta, Inc. (IBTA), and Inspire Medical Systems, Inc. (INSP)

Johnson Fistel, PLLP

February 11, 2026
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Atkore Inc. (ATKR), Axsome Therapeutics, Inc. (AXSM), Capricor Therapeutics, Inc. (CAPR), and CTO Realty Growth, Inc. (CTO)

Johnson Fistel, PLLP

February 11, 2026
Johnson Fistel, PLLP Begins Investigation on Behalf of Long-Term Shareholders of Firefly Aerospace Inc. (FLY), Flywire Corporation (FLYW), Fortinet, Inc. (FTNT), and Compass Diversified Holdings (CODI)

Johnson Fistel, PLLP

February 11, 2026
Johnson Fistel, PLLP Begins Investigation on Behalf of Long-Term Shareholders of DICK’s Sporting Goods, Inc. (DKS), Domino’s Pizza, Inc. (DPZ), Elanco Animal Health Incorporated (ELAN), and Elevance Health, Inc. (ELV)

Johnson Fistel, PLLP

February 11, 2026
Johnson Fistel, PLLP Begins Investigation on Behalf of Long-Term Shareholders of Replimune Group, Inc. (REPL), Sable Offshore Corp. (SOC), Sarepta Therapeutics, Inc. (SRPT), and Semler Scientific, Inc. (SMLR)

Johnson Fistel, PLLP

February 11, 2026
Johnson Fistel, PLLP Begins Investigation on Behalf of Long-Term Shareholders of Jasper Therapeutics, Inc. (JSPR), KBR, Inc. (KBR), LifeMD, Inc. (LFMD), and Lineage, Inc. (LINE)

Johnson Fistel, PLLP

February 11, 2026
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Beyond Meat, Inc. (NASDAQ: BYND)

Bernstein Liebhard LLP

February 11, 2026
CORCEPT THERAPEUTICS INCORPORATED (NASDAQ: CORT) INVESTIGATION ALERT: Bernstein Liebhard is Investigating Possible Securities Claims against Corcept Therapeutics Incorporated

Bernstein Liebhard LLP

February 11, 2026
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Vistagen Therapeutics, Inc. (NASDAQ: VTGN)

Bernstein Liebhard LLP

February 11, 2026

Follow Us